How to protect acutely ill, unconscious patients in connection with drug trials?
Berg, R.M.G.; Møller, K.; Rossel, P.J.H.
Ugeskrift for Laeger 173(12): 919
2011
ISSN/ISBN: 1603-6824 PMID: 21539130 Document Number: 655183
Document emailed within 1 workday
Related Documents
Fagrell, B.; Riddez, L. 2009: Change of law concerning drug trials is needed: Sweden should allow testing in unconscious patients Lakartidningen 106(48): 3217-3218Perner, A.; Bonde, J. 2005: Unprejudiced debate on drug research in unconscious patients Ugeskrift for Laeger 167(49): 4671; Author Reply 4671
Strelkov, R.B. 1967: Effect of neurolytic agents on the activity of sulfur containing radio protectors beta mercapto ethylamine radio protect cystamine radio protect beta aminoiso thiuronium bromide hydro bromide radio protect cysteine radio protect atropine radio protect hexonium radio protect methyl diazil radio protect dimedrol radio protect mouse Radiobiologiya 7(6): 939-940
Solaiman, T. 2010: RM matters: drug seekers. Protect yourself from patients who abuse pain medications Northwest Dentistry 89(1): 55-56
Schweim, H.G. 2005: Illegal drug trade discovered in Bavaria. How can we protect ourselves from drug falsification? MMW Fortschritte der Medizin 147(38): 11
Swain, S.M. 1998: Adult multicenter trials using dexrazoxane to protect against cardiac toxicity Seminars in Oncology 25(4 Suppl 10: 43-47
Bellamy, N.; Carette, S.; Ford, P.M.; Kean, W.F.; le Riche, N.G.; Lussier, A.; Wells, G.A.; Campbell, J. 1992: Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise Journal of Rheumatology 19(3): 451-457
Allain, H.; Bernard, P.M.; Dartigues, J.F.; Dérouesné, C.; Dubois, B.; Hugonot, L.; Laurent, B.; Léger, J.M.; Malauzat, D.; Michel, B. 1994: Viewpoint on the methodology of drug trials affecting cognition of elderly patients L'Encephale 20(6): 725-739
Ohlsen, B. 1982: Care of cancer patients - a psychological burden. 2. the unconscious dissociation from patients Sygeplejersken 82(31): 8-11
Bellamy, N.; Anastassiades, T.P.; Buchanan, W.W.; Davis, P.; Lee, P.; McCain, G.A.; Wells, G.A.; Campbell, J. 1991: Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs Journal of Rheumatology 18(12): 1901-1907
Amidon, T.M. 1995: Mi survivors: using drug therapies to protect the heart Geriatrics 50(10): 26-28; 31-34, 36
Winslade, W.J. 1993: Permanently unconscious patients: a radical proposal Texas Medicine 89(9): 16
Ayala, R.C.; Arya, V.; Younis, I.R. 2016: Design Features of Drug-Drug Interaction Trials Between Antivirals and Oral Contraceptives Journal of Clinical Pharmacology 56(5): 541-547
Mil'chakova, L.E.; Gekht, A.B. 2010: Efficacy and safety of a new antiepileptic drug lacosamide in patients with focal epilepsy: data of double-blind placebo controlled trials Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 110(3 Suppl 2: 39-43
Miller, C.A.; Hooper, C.L.; Bakish, D. 1997: A comparison of patients with major depressive disorder recruited through newspaper advertising versus consultation referrals for clinical drug trials Psychopharmacology Bulletin 33(1): 69-73
Sharma, D.C. 2004: India pressed to relax rules on clinical trials. Drug companies claim changes are essential, but critics fear Indian patients will become guinea pigs Lancet 363(9420): 1528-1529
Reilly, J. 2014: Drug testing & safety: what's the connection? Occupational Health and Safety 83(9): 80 82
Danielsson, S. 2002: Is there a risk of revision in connection with the drug reform? Lakartidningen 99(20): 2332
Cleaver, B.; Elftman, J.; Grip, A. 2018: A retrospective analysis of the management of unconscious patients from the emergency room (ER) to intensive care (ICU) at Södersjukhuset Lakartidningen 115
Desai, N.M. 1981: Management of acutely disturbed patients British Journal of Hospital Medicine 26(6): 653